Zydus Lifesciences Ltd. (ZYDUSLIFE) - Financials, balance sheet (annual)

967 INR

0.15

0.02%

Last update Jul 16, 3:29 PM IST

Main market

Day range

967

963.5

977.70001

Previous close

967.15002

Open

977.70001

Access this stock data via API

Zydus Lifesciences Ltd.

967.00

0.15

0.02%

Financials

Balance sheet

Fiscal date	2025	2024	2023	2022
Total assets	372.0B	292.8B	257.6B	278.0B
Current assets	170.5B	115.0B	100.2B	122.6B
Cash	—	4.1B	4.9B	6.6B
Cash equivalents	—	—	—	—
Cash and cash equivalents	8.3B	4.1B	4.9B	6.6B
Other short term investments	74.9B	9.7B	7.2B	28.2B
Accounts receivable	40.2B	52.2B	44.2B	33.4B
Other receivables	771M	2.7B	1.5B	1.5B
Inventory	39.4B	34.4B	34.1B	37.2B
Prepaid assets	—	7.2B	7.3B	13.2B
Restricted cash	—	46M	48M	54M
Assets held for sale	0	816M	82M	1.7B
Hedging assets	—	2.8B	0	—
Other current assets	6.8B	175M	186M	48M
Non current assets	201.6B	177.8B	157.4B	155.3B
Properties	60.4B	58.0B	57.0B	57.6B
Land and improvements	—	6.2B	6.3B	5.7B
Machinery furniture equipment	—	80.8B	75.0B	71.3B
Construction in progress	13.2B	11.1B	11.3B	6.6B
Leases	—	—	—	—
Accumulated depreciation	—	-50.8B	-45.0B	-39.1B
Goodwill	137.1B	131.4B	107.0B	118.6B
Investment properties	—	—	—	—
Financial assets	—	0	1.8B	1.7B
Intangible assets	32.2B	26.1B	10.9B	11.3B
Investments and advances	—	—	—	—
Other non current assets	2.6B	210M	181M	144M
Total liabilities	108.4B	71.8B	60.7B	87.4B
Current liabilities	90.4B	53.4B	55.3B	78.4B
Accounts payable	23.1B	21.3B	21.3B	21.4B
Accrued expenses	—	—	—	—
Short term debt	31.8B	7.8B	11.8B	38.4B
Deferred revenue	—	—	—	—
Tax payable	6.2B	3.7B	1.6B	418M
Pensions	—	—	—	—
Other current liabilities	2.7B	396M	510M	345M
Non current liabilities	18.0B	18.4B	5.4B	9.0B
Long term provisions	3.8B	3.1B	2.7B	3.3B
Long term debt	321M	251M	198M	3.8B
Provision for risks and charges	—	—	—	—
Deferred liabilities	5.1B	4.5B	1.9B	1.5B
Derivative product liabilities	—	—	—	—
Other non current liabilities	9M	18M	—	3M
Shareholders equity
Common stock	1.0B	1.0B	1.0B	1.0B
Retained earnings	—	203.7B	171.9B	155.0B
Other shareholders equity	—	—	—	—
Total shareholders equity	263.6B	221.0B	196.9B	190.5B
Additional paid in capital	—	18M	12M	0
Treasury stock	—	—	—	—
Minority interest	24.1B	22.7B	21.7B	20.5B